Skip to main content

Security report for woerwagpharma.de

Wörwag Pharma GmbH & Co. KG · Healthcare · Germany

Low risk. 2 critical or high findings in Security headers and SSL/TLS.

Security score

79/100

Risk levelLow

0–100, higher is better. How it is calculated

Wörwag Pharma GmbH & Co. KG is a medium-sized, family-owned pharmaceutical company based in Germany with over 50 years of experience. The company focuses on healthcare products including prescription drugs, OTC medicines, and nutritional supplements, targeting patients, healthcare professionals, and pharmacies. The website is professionally designed using TYPO3 CMS, with a strong emphasis on user experience, mobile optimization, and clear navigation. It supports multiple languages and international markets, reflecting a mature digital presence. Security posture is solid with HTTPS and consent management implemented, though some security headers and explicit policies could be improved. Privacy compliance is well addressed with comprehensive privacy and cookie policies. Overall, the website reflects a trustworthy and credible business with a good balance of technical sophistication and regulatory compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
5of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching woerwagpharma.de

This scan found 12 issues across 4 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
70
Network security
100
GDPR outside view
83
Average
79

Not counted

  • Email security: did not complete in this scan.
  • DNS health: did not complete in this scan.
  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company operates in the healthcare sector with a focus on pharmaceutical manufacturing and distribution. It maintains a broad international footprint with localized domains across Europe, Asia, and South America. The business model centers on product innovation and service to healthcare professionals, supported by dedicated portals and career sites. The firm leverages partnerships and subsidiaries such as Wörwag Pharma Operations to extend its operational capabilities. Growth indicators include recent product launches and dynamic market presence. The company emphasizes quality, trust, and patient-centric values, positioning itself as a reliable player in the pharmaceutical industry.

Security posture

The website demonstrates a mature security posture with enforced HTTPS, use of a consent management platform (Usercentrics), and no visible exposure of sensitive data. However, the absence of explicit security policies, incident response contacts, and security.txt files indicates room for improvement in transparency and readiness. No vulnerable libraries or critical security issues were detected in the HTML content. Recommendations include implementing security headers, publishing security policies, and establishing clear incident response channels to enhance trust and compliance.

Recommendations

  1. Implement HTTP security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
  2. Publish a dedicated security policy page and provide incident response contact information.
  3. Add a security.txt file to facilitate vulnerability disclosures.
  4. Regularly audit third-party scripts and libraries for vulnerabilities.
  5. Enhance form input validation and monitoring to prevent injection attacks.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Wörwag Pharma GmbH & Co. KG
Description
Die Gesundheit unserer Mitmenschen ist das Hauptaugenmerk von Wörwag Pharma. Darum hören wir besser zu, sehen genauer hin und helfen noch wirksamer.
Key services
Pharmaceutical products, OTC medicines, Nutritional supplements, Medical information and services for healthcare professionals
Content quality
excellent
Branding
consistent

Technology

Stack
TYPO3 CMS, jQuery 3.7.1, Google Tag Manager, Usercentrics Consent Management, Swiper.js
Frameworks
TYPO3
Performance
moderate
Mobile
excellent
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Consent management via Usercentrics
  • No exposed sensitive data in HTML
  • Secure forms with validation

Analytics and tracking

Services
Google Analytics (via Google Tag Manager)
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
Usercentrics Consent Management
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges
  2. Content is rich, professionally presented, and well-structured
  3. Strong focus on healthcare and pharmaceutical products
  4. Good privacy and cookie policy implementation with consent management
  5. No explicit security policy or incident response contacts found
  6. WHOIS data uses proxy nameservers but no suspicious patterns detected
  7. Multiple international localized domains indicate broad market presence
  8. Use of modern CMS TYPO3 and standard web technologies
  9. Social media presence on LinkedIn, YouTube, and Xing
  10. No exposed sensitive data or obvious vulnerabilities in HTML
Technical notes

Notes

The website is built on TYPO3 CMS, a robust and scalable content management system suitable for enterprise use. It uses modern JavaScript libraries including jQuery and Swiper.js for UI components and Google Tag Manager for analytics. Consent management is handled by Usercentrics, ensuring GDPR compliance. The site is mobile-optimized with responsive design and preloading of fonts and assets for performance. Hosting details are not explicit but DNS uses rrpproxy.net nameservers indicating privacy protection. Performance is moderate with good SEO and accessibility features. Technical risks are minimal but could be further mitigated by enhancing security headers and monitoring.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with woerwagpharma.de. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review woerwagpharma.de.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.